Señales en vivo de MEUSW | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development...

Stats
Volumen de hoy	235 963
Volumen promedio	188 428
Capitalización de mercado	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.342 (24.78%)

Volumen Correlación

Largo: 0.23 (neutral)

Corto: -0.25 (neutral)

Signal:(27.187) Neutral

23andMe Holding Co. Correlación

10 Correlaciones Más Positivas
VTYX	0.929
RGTI	0.91
ARQQ	0.875
IPWR	0.869
SOUN	0.862
RCM	0.86
GOSS	0.857
OCUL	0.855
OPTN	0.854
FEMY	0.85

10 Correlaciones Más Negativas
DSPC	-0.834

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

23andMe Holding Co. Correlación - Moneda/Commodity

0.48
( neutral )

0.46
( neutral )

0.00
( neutral )

0.22
( neutral )

-0.42
( neutral )

23andMe Holding Co. Finanzas

Annual	2022
Ingresos:	$299.49M
Beneficio Bruto:	$134.50M (44.91 %)
EPS:	$-0.690

FY	2022
Ingresos:	$299.49M
Beneficio Bruto:	$134.50M (44.91 %)
EPS:	$-0.690

FY	2022
Ingresos:	$271.89M
Beneficio Bruto:	$132.95M (48.90 %)
EPS:	$-0.600

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$50.53

Financial Reports:

No articles found.

23andMe Holding Co.

23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.